The present study aimed to determine the abuse prevalence and risk factors among individuals with SCI in Ilam during the COVID-19 pandemic. This is the first study in the world to compare the prevalence of abuse in patients with SCI during the COVID-19 pandemic. Therefore, the findings of the current study will be compared with other studies performed at other times. Attention to chronic patients, especially the psychological issues of these patients, should be prioritized as one of the essential tasks of healthcare staff (
23). Another important and necessary issue that necessitates attention to vulnerable groups is emerging diseases, such as COVID-19. The spread of this disease has created various challenges and problems for distinct vulnerable patient groups, including SCI cases (
24).
According to our findings, the abuse prevalence was higher in women than men, which is consistent with the results of Brandao et al. in Brazil (68.9%) (
25) and El-Khawaga et al. in Egypt (56.6%) (
26). The present study also revealed that the abuse prevalence was higher in older patients, which is consistent with the findings of the study by Sathya et al. These authors showed that the rate of elder abuse increased with age (
27). With age, the disability of the elderly exacerbates, and this factor can lead to an elevation in elder abuse (
27,
28).
The current study results also demonstrated that patients experienced abuse during the COVID-19 pandemic in 42.45% of cases. El-Khawaga et al. in Egypt showed that the elderly with chronic diseases experienced more frequent abuse than the elderly without chronic diseases, which is similar to our results concerning abuse in patients with SCI (
26). In a meta-analysis of 15 articles on the abuse prevalence in the elderly in Iran during 2005 - 2017, Abdi et al. indicated that abuse prevalence was 48.3% in this age group (
3). Moreover, in a meta-analysis of elder abuse in 28 countries, Yon et al. reported the abuse rate as 15.7% (
29), which shows the presence of abuse among older people. Farnia et al. reported the abuse prevalence in the Spanish and Iranian elderly groups as 80.5% and 39.1%, respectively, which was much higher in the Iranian elderly than the Spanish elderly. The mentioned finding is consistent with the results of the present study that showed patients with SCI experienced abuse in 42.45% of cases (
30).
Furthermore, in a study on the elderly group in Qazvin, Oveisi et al. found that these people experienced financial, psychological, or neglect abuse in at least 80% of cases (
31), which is more than our study. This discrepancy may result from the differences in the study population and study instruments. It should also be noted that the present study investigated the abuse prevalence during the COVID-19 pandemic.
There were no cross-sectional and epidemiological studies on the abuse prevalence during the COVID-19 pandemic. However, similar investigations can be mentioned. For example, Karimian et al., in their letter to the editor, published during the early outbreak of COVID-19 in 2020, emphasized the importance of abuse prevention during COVID-19 in elderly individuals (
15). In a retrospective study, Sharma et al. showed that child abuse prevalence was 158, 199, 204, and 215 cases in 2017, 2018, 2019, and 2020, respectively, which indicates an increasing trend during COVID-19 (
32). Moreover, Sserwanja et al. revealed that the rate of physical, sexual, and child abuse, as well as child labor, has augmented since the beginning of the COVID-19 outbreak (
14), which is consistent with the results of the present study.
5.1. Conclusions
In the present study, the variables of age, gender, and time of SCI were effective in the abuse of patients with SCI. Therefore, it is necessary to take preventive measures in this regard. Moreover, the prevalence of abuse related to COVID-19 in patients was 42.45%. It is recommended to consider the novel results of this study in practice. In addition, similar studies are suggested to be conducted in other cities of Iran and other countries to provide more comprehensive and extensive information for health policymakers.